|
|
|
|
|
||
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 107, Issue 9 2581-2590, Copyright © 1994 by Company of Biologists
JOURNAL ARTICLES |
M Yamagata and K Kimata
Institute for Molecular Science of Medicine, Aichi Medical University, Japan.
Malignantly transformed cells usually display a rosette-like morphology of substratum adhesions (called podosomes) and disorganized microfilaments, and are often associated with elevated production of chondroitin sulphate. We previously showed that many tissues and cells express alternatively spliced multiforms of the large chondroitin sulphate proteoglycan termed PG-M (versican is one of the short transcripts). Since PG-M/versican inhibits many types of cell-substratum adhesion and is found to be excluded from focal contacts of cultured fibroblasts, it is likely that this proteoglycan is generally involved in regulating cell-substratum adhesion. We report here that PG-M/versican is selectively excluded from podosomes of human osteosarcoma cells and that specific inhibition of its biosynthesis by an antisense method suppresses such a malignant cell-adhesive phenotype. The results support the idea that PG-M/versican acts as an anti-adhesive molecule and raise the possibility that PG-M/versican controls one type of cancer cell behaviour.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Osada, C. Hamada, T. Shimaoka, K. Kaneko, S. Horikoshi, and Y. Tomino Alterations in proteoglycan components and histopathology of the peritoneum in uraemic and peritoneal dialysis (PD) patients Nephrol. Dial. Transplant., November 1, 2009; 24(11): 3504 - 3512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Suwan, K. Choocheep, S. Hatano, P. Kongtawelert, K. Kimata, and H. Watanabe Versican/PG-M Assembles Hyaluronan into Extracellular Matrix and Inhibits CD44-mediated Signaling toward Premature Senescence in Embryonic Fibroblasts J. Biol. Chem., March 27, 2009; 284(13): 8596 - 8604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. von Marschall and L. W. Fisher Dentin Matrix Protein-1 Isoforms Promote Differential Cell Attachment and Migration J. Biol. Chem., November 21, 2008; 283(47): 32730 - 32740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kihara, Y. Imamura, Y. Takemura, K. Mizuno, E. Adachi, and T. Hayashi Intercellular Accumulation of Type V Collagen Fibrils in Accordance with Cell Aggregation J. Biochem., November 1, 2008; 144(5): 625 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Koyama, T. Hibi, Z. Isogai, M. Yoneda, M. Fujimori, J. Amano, M. Kawakubo, R. Kannagi, K. Kimata, S. Taniguchi, et al. Hyperproduction of Hyaluronan in Neu-Induced Mammary Tumor Accelerates Angiogenesis through Stromal Cell Recruitment: Possible Involvement of Versican/PG-M Am. J. Pathol., March 1, 2007; 170(3): 1086 - 1099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kamiya, H. Watanabe, H. Habuchi, H. Takagi, T. Shinomura, K. Shimizu, and K. Kimata Versican/PG-M Regulates Chondrogenesis as an Extracellular Matrix Molecule Crucial for Mesenchymal Condensation J. Biol. Chem., January 27, 2006; 281(4): 2390 - 2400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Sakko, C. Ricciardelli, K. Mayne, S. Suwiwat, R. G. LeBaron, V. R. Marshall, W. D. Tilley, and D. J. Horsfall Modulation of Prostate Cancer Cell Attachment to Matrix by Versican Cancer Res., August 15, 2003; 63(16): 4786 - 4791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Touab, J. Villena, C. Barranco, M. Arumi-Uria, and A. Bassols Versican Is Differentially Expressed in Human Melanoma and May Play a Role in Tumor Development Am. J. Pathol., February 1, 2002; 160(2): 549 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Evanko, J. C. Angello, and T. N. Wight Formation of Hyaluronan- and Versican-Rich Pericellular Matrix Is Required for Proliferation and Migration of Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, April 1, 1999; 19(4): 1004 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M Culav, C H. Clark, and M. J Merrilees Connective Tissues: Matrix Composition and Its Relevance to Physical Therapy Physical Therapy, March 1, 1999; 79(3): 308 - 319. [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang, L. Cao, C. G. Kiani, B. L. Yang, and B. B. Yang The G3 Domain of Versican Inhibits Mesenchymal Chondrogenesis via the Epidermal Growth Factor-like Motifs J. Biol. Chem., December 4, 1998; 273(49): 33054 - 33063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Henderson and A. J. Copp Versican Expression Is Associated With Chamber Specification, Septation, and Valvulogenesis in the Developing Mouse Heart Circ. Res., September 7, 1998; 83(5): 523 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang, L. Cao, B. L. Yang, and B. B. Yang The G3 Domain of Versican Enhances Cell Proliferation via Epidermial Growth Factor-like Motifs J. Biol. Chem., August 14, 1998; 273(33): 21342 - 21351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Lemire, S. Potter-Perigo, K. L. Hall, T. N. Wight, and S. M. Schwartz Distinct Rat Aortic Smooth Muscle Cells Differ in Versican/PG-M Expression Arterioscler Thromb Vasc Biol, June 1, 1996; 16(6): 821 - 829. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Landolt, L Vaughan, K. Winterhalter, and D. Zimmermann Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth Development, January 8, 1995; 121(8): 2303 - 2312. [Abstract] [PDF]
|
|
